Director, Hematology Clinical Intelligence & RWE Strategy

Role: Lead end-to-end evidence strategy for Hematology, integrating clinical R&D and patient care insights to inform portfolio decisions, regulatory filings, and market access. Responsibilities: identify and prioritize evidence gaps, leverage multimodal data (genomics, imaging, digital endpoints, AI), and develop AI-enabled approaches for tumor dynamics, prognosis, and trial simulations. Collaborate with Translational Science, Clinical Development, and Market Access to translate complex data into actionable intelligence, influencing senior stakeholders across a matrixed environment. Requirements: advanced degree (PhD, MD, PharmD) in epidemiology, biostatistics, or related, with 5+ years in evidence generation, RWE, or health outcomes research within pharma, biotech, or academia. Expertise in RWE assets, observational study design, causal inference, and multimodal modeling. Preferred: familiarity with AI/ML applications in RWE and AI-enabled evidence platforms. High-Value: Hematology, evidence generation, RWE, multimodal data, AI/ML, clinical development, regulatory and market access interfaces. Location: Boston, MA (hybrid; in-office 3+ days/week); options for London or Barcelona under specific conditions.